Provided by Tiger Trade Technology Pte. Ltd.

AEON Biopharma

0.2900
+0.059025.54%
Post-market: 0.30400.0140+4.83%18:56 EDT
Volume:203.07M
Turnover:64.56M
Market Cap:14.47M
PE:-0.08
High:0.3544
Open:0.2960
Low:0.2800
Close:0.2310
52wk High:1.45
52wk Low:0.1772
Shares:49.88M
Float Shares:30.51M
Volume Ratio:518.42
T/O Rate:665.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5840
EPS(LYR):-3.9532
ROE:--
ROA:-141.53%
PB:-0.94
PE(LYR):-0.07

Loading ...

Company Profile

Company Name:
AEON Biopharma
Exchange:
AMEX
Establishment Date:
- -
Employees:
8
Office Location:
5 Park Plaza,Suite 1750,Irvine,California,United States
Zip Code:
92614
Fax:
- -
Introduction:
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.